Covaxin safe, induces immune response with no severe effects: Lancet
Tuesday, 9 March 2021 In an encouraging development for India's vaccination drive, leading UK medical journal The Lancet on Tuesday said that indigenously developed Covaxin was found to be safe and has demonstrated better performance in the Phase 2 trials compared to Phase 1.
The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."